US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney disease progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney ...
Hosted on MSN44m
Can-Fite BioPharma secures US patent for Namodenoson
Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.
As RFK Jr.‘s hearings begin, so will scrutiny on his familiarity with key health programs
The job Robert F. Kennedy Jr. is seeking is defined by the task of overseeing Medicare and Medicaid, which he's shown little ...
Texas Public Radio53m
Caroline Kennedy calls her cousin, RFK, Jr., a 'predator' ahead of his confirmation hearings
In a letter, Kennedy said RFK Jr. was 'unqualified' to be the new U.S. Department of Health and Human Services secretary just ...